<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:atom="http://www.w3.org/2005/Atom" version="2.0">
  <channel>
    <title>Forma Life Sciences</title>
    <link>https://www.biospace.com/employer/3076399/forma-life-sciences</link>
    <description>Forma Life Sciences</description>
    <language>en-US</language>
    <lastBuildDate>Wed, 04 Mar 2026 06:02:35 GMT</lastBuildDate>
    <atom:link href="https://www.biospace.com/employer/3076399/forma-life-sciences.rss" type="application/rss+xml" rel="self" />
    <item>
      <title>Forma Life Sciences Launches U.S. Based Contract Development and Manufacturing Organization (CDMO) for Oral Solid Dosage Development and Commercial Manufacturing in Irvine, California</title>
      <link>https://www.biospace.com/press-releases/forma-life-sciences-launches-u-s-based-contract-development-and-manufacturing-organization-cdmo-for-oral-solid-dosage-development-and-commercial-manufacturing-in-irvine-california</link>
      <description />
      <pubDate>Wed, 04 Mar 2026 06:02:35 GMT</pubDate>
      <guid>https://www.biospace.com/press-releases/forma-life-sciences-launches-u-s-based-contract-development-and-manufacturing-organization-cdmo-for-oral-solid-dosage-development-and-commercial-manufacturing-in-irvine-california</guid>
    </item>
    <item>
      <title>Cycle Pharmaceuticals Selects Forma Life Sciences to Establish U.S. Commercial Supply for FDA-Approved CAVHANZA™ (nilotinib) Orally Disintegrating Tablets</title>
      <link>https://www.biospace.com/press-releases/cycle-pharmaceuticals-selects-forma-life-sciences-to-establish-u-s-commercial-supply-for-fda-approved-cavhanza-nilotinib-orally-disintegrating-tablets</link>
      <description />
      <pubDate>Thu, 13 Aug 2026 04:18:11 GMT</pubDate>
      <guid>https://www.biospace.com/press-releases/cycle-pharmaceuticals-selects-forma-life-sciences-to-establish-u-s-commercial-supply-for-fda-approved-cavhanza-nilotinib-orally-disintegrating-tablets</guid>
    </item>
  </channel>
</rss>
